Chitosan-Based Materials for Peripheral Nerve Repair-New Pre-Clinical Data on Degradation Behavior at the Nerve Repair Site and Critical Opinion on Their Translational Impact.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

Original Publication: Basel, Switzerland : MDPI, [2000-

Chitosan*/chemistry ; Chitosan*/pharmacology ; Nerve Regeneration*/drug effects ; Biocompatible Materials*/chemistry ; Biocompatible Materials*/pharmacology ; Median Nerve*/drug effects ; Peripheral Nerves*/drug effects ; Peripheral Nerve Injuries*/therapy; Animals ; Rats ; Male

Before clinical approval of chitosan nerve conduits (CNCs) less than 10 years ago, substantial material degradation was not reported from pre-clinical research. The current study investigated the biodegradation of two different CNC variants in the median nerve model. In adult rats, 10 mm long CNCs were secured covering end-to-end repair sites. After 2, 6, 12, and 18 months, the implantation sites were inspected, and samples harvested. Histology was performed in order to analyze local immune response or foreign body tissue reaction around the devices or within nerve samples. Further, the number of myelinated nerve fibers and the condition of the chitosan material was evaluated. Data confirmed that different CNC variants did not induce tissue reaction or negatively impact the condition of the regenerated nerve. At late time points, some specific variants were demonstrated to have resulted in encapsulated material debris in the vicinity of the original implantation side. The reported degradation behavior resembles recent clinical reports and indicates that implantation sites for CNCs need to be chosen carefully. Nerve regeneration itself is undisturbed, but narrow implantation sites should be avoided for eliminating the risk of foreign body sensation with immunologically inert material degradation.

Bioengineering (Basel). 2024 Jul 31;11(8):. (PMID: 39199733)
Int J Mol Sci. 2023 May 24;24(11):. (PMID: 37298122)
J Hand Ther. 2005 Apr-Jun;18(2):191-7. (PMID: 15891977)
Front Cell Dev Biol. 2024 Jul 01;12:1431558. (PMID: 39011392)
Plast Reconstr Surg. 2025 Feb 1;155(2):364-373. (PMID: 38722615)
Front Cell Neurosci. 2019 Apr 04;13:104. (PMID: 31019452)
Trials. 2016 Jan 26;17:48. (PMID: 26811067)
Int Rev Neurobiol. 2009;87:81-103. (PMID: 19682634)
Front Neurol. 2024 Jun 21;15:1420324. (PMID: 38974681)
Int J Mol Sci. 2024 Jun 12;25(12):. (PMID: 38928194)
Front Cell Dev Biol. 2024 Nov 14;12:1499766. (PMID: 39610708)
Pharmaceutics. 2023 Jan 25;15(2):. (PMID: 36839722)
Biomolecules. 2023 Nov 27;13(12):. (PMID: 38136583)
Front Neurol. 2024 Jan 22;14:1307883. (PMID: 38318237)
Front Cell Neurosci. 2019 May 10;13:149. (PMID: 31133803)
Int J Mol Sci. 2023 Jan 17;24(3):. (PMID: 36768142)
Int J Biol Macromol. 2024 Jul;273(Pt 1):132768. (PMID: 38823733)
J Hand Surg Eur Vol. 2012 May;37(4):342-9. (PMID: 21987277)
J Pers Med. 2022 May 30;12(6):. (PMID: 35743685)
Handchir Mikrochir Plast Chir. 2023 Sep;55(5):373-375. (PMID: 36889327)
Biomaterials. 2016 Jan;76:33-51. (PMID: 26517563)
Biomed Res Int. 2018 Jun 4;2018:6982738. (PMID: 29967779)

RDV-0002 Kerimedical Suisse

Keywords: chitosan nerve guide; degradation in vivo; nerve regeneration

9012-76-4 (Chitosan)
0 (Biocompatible Materials)

Date Created: 20250213 Date Completed: 20250507 Latest Revision: 20250507

20250508

PMC11818691

10.3390/ijms26031214

39940983